Also trades as: PTIXW (NASDAQ) · $vol 0M
PTIX OTC
Protagenic Therapeutics, Inc.
1W: +0.0%
1M: -26.3%
3M: +248.8%
YTD: +4.6%
1Y: -77.1%
3Y: -96.9%
5Y: -99.3%
$0.77
-0.01 (-0.78%)
Weekly Expected Move ±17.6%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2021-04-30
Earliest Filing
2025-05-19
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named PTIX in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| PTIXW Protagenic Therapeutics, Inc.\new | target | Company entering Registration Rights Agreement | 2025-05-19 | View |
| PTIXW Protagenic Therapeutics, Inc.\new | target | Company entering into amendment for at market issuance sales agreement | 2025-01-10 | View |
| PTIXW Protagenic Therapeutics, Inc.\new | partner | Company issuing securities in the offering | 2021-04-30 | View |
Recent 8-K Filings (1)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-20 | Regulation FD; Other Events; Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR